Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cadrenal Therapeutics, Inc. | 182,161 | reported | 28 May 2026 | tx 28+415,000−171,172 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | SALE | Cadrenal Therapeutics, Inc. | 6,476 | 5.76 USD | 10b5-1 |
| 12 May 2026 | SALE | Cadrenal Therapeutics, Inc. | 3,298 | 5.28 USD | 10b5-1 |
| 28 May 2026 | SALE | Cadrenal Therapeutics, Inc. | 2,989 | 4.93 USD | 10b5-1 |
| 22 May 2026 | SALE | Cadrenal Therapeutics, Inc. | 1,165 | 5.69 USD | 10b5-1 |
| 24 Oct 2025 | SALE | Cadrenal Therapeutics, Inc. | 1,129 | 14.03 USD | |
| 27 Oct 2025 | SALE | Cadrenal Therapeutics, Inc. | 1,315 | 13.99 USD | |
| 13 Oct 2025 | SALE | Cadrenal Therapeutics, Inc. | 1,800 | 14.15 USD | |
| 09 Oct 2025 | SALE | Cadrenal Therapeutics, Inc. | 1,800 | 14.02 USD | |
| 02 Oct 2025 | SALE | Cadrenal Therapeutics, Inc. | 500 | 14.13 USD | |
| 01 Oct 2025 | SALE | Cadrenal Therapeutics, Inc. | 881 | 14.01 USD | |
| 29 Sept 2025 | SALE | Cadrenal Therapeutics, Inc. | 419 | 14.01 USD | |
| 24 Sept 2025 | SALE | Cadrenal Therapeutics, Inc. | 2,581 | 13.99 USD | |
| 25 Sept 2025 | SALE | Cadrenal Therapeutics, Inc. | 6,790 | 14.09 USD | |
| 27 Aug 2025 | SALE | Cadrenal Therapeutics, Inc. | 3,836 | 13.99 USD | |
| 28 Aug 2025 | SALE | Cadrenal Therapeutics, Inc. | 1,193 | 13.99 USD | |
| 23 Jan 2025 | GRANT_AWARD | Cadrenal Therapeutics, Inc. | 65,000 | 0.00 USD | deriv |
| 10 Apr 2024 | GIFT | Cadrenal Therapeutics, Inc. | 50,000 | 0.00 USD | |
| 23 Oct 2023 | GIFT | Cadrenal Therapeutics, Inc. | 85,000 | 0.00 USD | |
| 18 Jan 2024 | GRANT_AWARD | Cadrenal Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 05 Sept 2023 | PURCHASE | Cadrenal Therapeutics, Inc. | 20,000 | 0.91 USD | |
| 05 Sept 2023 | PURCHASE | Cadrenal Therapeutics, Inc. | 20,000 | 0.90 USD | |
| 01 Sept 2023 | PURCHASE | Cadrenal Therapeutics, Inc. | 10,000 | 0.93 USD | |
| 01 Sept 2023 | PURCHASE | Cadrenal Therapeutics, Inc. | 10,000 | 0.84 USD | |
| 01 Sept 2023 | PURCHASE | Cadrenal Therapeutics, Inc. | 10,000 | 0.92 USD | |
| 01 Sept 2023 | PURCHASE | Cadrenal Therapeutics, Inc. | 20,000 | 0.93 USD |